Marshall JC, Vincent JL, Fink MP, et al. Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. Crit Care Med.2003;31:1560-1567.
2.
Michaela K.Molecular physiology of natriuretic peptide signalling. Basic Res Cardiol. 2004;99:76-82.
3.
Sudoh T., Kangawa K., Minamino N., Matsuo H.A new natriuretic peptide in porcine brain. Nature1988;332:78-81.
4.
La Villa G., Fronzaroli C., Lazzeri C., et al. Cardiovascular and renal effects of low dose brain natriuretic peptide infusion in man. J Clin Endocrinol Metab.1994;78:1166-1171.
5.
McLean AS , Huang SJ, Nalos M., Tang B., Stewart DEThe confounding effects of age, gender, serum creatinine, and electrolyte concentrations on plasma B-type natriuretic peptide concentrations in critically ill patients. Crit Care Med.2003;31:2611-2618.
6.
Olsen MH, Hansen TW, Christensen MK, et al. N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension. 2005;46:660-666.
7.
Rudiger A., Gasser S., Fischler M., et al. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med.2006;34:2140-2144.
8.
Charpentier J., Luyt CE, Fulla Y., et al. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med.2004;32:660-665.
9.
Rivers E., McCord J., Otero R., Jacobsen G., Loomba M.Clinical utility of B-type natriuretic peptide in early severe sepsis and septic shock. J Intensive Care Med.2007;22:363-373.
10.
Parrillo J. , Parker M., Natanson C., et al. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy . Ann Intern Med.1990;113:227-242.
11.
McLean AS, Huang SJThe applications of B-type natriuretic peptide measurement in the intensive care unit. Curr Opin Crit Care . 2005;11:406-412.
12.
Shor R., Rozenman Y., Bolshinsky A., et al. BNP in septic patients without systolic myocardial dysfunction . Eur J Intern Med.2006;17:536-540.
13.
Witthaut R.Natriuretic peptides in critical illness. Crit Care. 2004;8:342-349.
14.
Kerbaul F., Giorgi R., Oddoze C., et al. High concentrations of N-BNP are related to non-infectious severe SIRS associated with cardiovascular dysfunction occurring after off-pump coronary artery surgery. Br J Anaesth.2004;93:639-644.
15.
Fukui S., Katoh H., Tsuzuki N., et al. Focal brain edema and natriuretic peptides in patients with subarachnoid hemorrhage. JClin Neurosci.2004;11:507-511.
16.
McGirt MJ, Blessing R., Nimjee SM, et al. Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery. 2004 ;54:1369-1373.
17.
Giannakoulas G., Hatzitolios A., Karvounis H., et al. N-terminal pro-brain natriuretic peptide levels are elevated in patients with acute ischemic stroke. Angiology. 2005;56: 723-730.
18.
Sviri GE, Soustiel JF, Zaaroor M.Alteration in brain natriuretic peptide (BNP) plasma concentration following severe traumatic brain injury. Acta Neurochir.2006;148:529-533.
19.
Yip HK, Sun CK, Chang LT, et al. Time course and prognostic value of plasma levels of N-terminal pro-brain natriuretic peptide in patients after ischemic stroke. Circ J. 2006; 70:447-452.
20.
Tsubokawa T. , Shiokawa Y., Kurita H., Kaneko N.High plasma concentration of brain natriuretic peptide in patients with ruptured anterior communicating artery aneurysm. Neurol Res.2004;26:893-896
21.
Berendes E. , Walter M., Cullen P., et al. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet . 1997;349:245-249.
22.
Nakagawa K. , Yamaguchi T., Seida M., et al. Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke. Cerebrovasc Dis. 2005;19:157-164.
23.
Papadopoulos MC, Davies DC, Moss RF, et al. Pathophysiology of septic encephalopathy: a review. Crit Care Med.2000;28:3019-3024.
24.
Maeder M., Ammann P., Kiowski W., Rickli H.B-type natriuretic peptide in patients with sepsis and preserved left ventricular ejection fraction. Eur J Heart Fail. 2005;7: 1164-1167.
25.
Taylor JA, Christenson RH, Rao K., Jorge M., Gottlieb SSB-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures . Am Heart J.2006;152: 1071-1076.
26.
Dessi-Fulgheri P., Sarzani R., Rappelli A.Role of the natriuretic peptide system in lipogenesis/lipolysis. Nutr Metab Cardiovasc Dis. 2003;13:244-249.
